Genetic Characteristics of Metastatic Breast Cancer Patients

  • STATUS
    Recruiting
  • End date
    Jul 31, 2024
  • participants needed
    300
  • sponsor
    Samsung Medical Center
Updated on 23 January 2021
breast cancer

Summary

Genomic analysis for metastatic breast cancer(MBC) patients

  • Participant (Inclusion criteria)
    1. Patients who diagnosed metastatic/stage IV breast cancer
    2. Patients who were not received treatment for metastatic breast cancer on palliative setting
  • Process

(1) Tissue/ Blood sample

  • At diagnosis, MBC tissue / blood sample (20cc) will be obtained.
  • At disease progression after 1st line treatment for MBC, blood sample (20cc) will be obtained (tissue; optional)

(2) WES, RNASeq, ctDNA, Exosome

  • We will analyze genomic characteritics using WES, RNASeq, ctDNA, Exosome.

Details
Condition Metastatic Breast Cancer, Stage IV Breast Cancer
Treatment Genomic analysis
Clinical Study IdentifierNCT04258735
SponsorSamsung Medical Center
Last Modified on23 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 18 yrs?
Gender: Male or Female
Do you have Metastatic Breast Cancer?
Do you have any of these conditions: Metastatic Breast Cancer or Stage IV Breast Cancer?
Patients who diagnosed ad metastatic breast cancer
Patients who were not received treatment on palliative setting

Exclusion Criteria

Patients who did not agree this study
Patients who did not have any pathologic specimen at MBC diagnosis
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note